Ndeye Coumba Toure Kane

TL;DR: This study shows that clinical and biologic results similar to those seen in Western countries can be achieved and sustained during the long term in Africa.

TL;DR: The prevention campaigns, STI and HIV care and support programs conducted in Senegal among MSM have been followed by a reduction of risk-taking behaviors and STI prevalence among this population and specific targeting of this group within HIV/STI prevention programs seems to be effective in decreasing sexual infections.

TL;DR: The virological outcome and HIV‐1 drug resistance in three West African countries using dried blood spots (DBS) samples is reported.

TL;DR: The results call for a strengthened collaboration with religious leaders and a focus on risk perception to rationalize preventive actions, and encourage the targeting of vulnerable populations, such as women in rural areas, by developing preventive messages to be delivered through national media and by staff from health centers, which most women visit, at least for prenatal care.

TL;DR: The study shows that SARS-CoV-2 strains have evolved over time and the variability of the virus is characterized by sequencing during each wave, as is its contagiousness (the speed at which it spreads).